{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:32:03Z","timestamp":1786480323020,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015851","name":"OPKO Health","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100015851","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015851","name":"OPKO Health","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100015851","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.34067\/kid.0000000982","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T16:00:48Z","timestamp":1756224048000},"page":"2000-2002","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Managing Dysregulated Vitamin D Metabolism in CKD"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7877-6795","authenticated-orcid":false,"given":"Charles W.","family":"Bishop","sequence":"first","affiliation":[{"name":"Renal Division, OPKO Health, Inc., Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhtar","family":"Ashfaq","sequence":"additional","affiliation":[{"name":"Renal Division, OPKO Health, Inc., Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1019-3849","authenticated-orcid":false,"given":"John","family":"Choe","sequence":"additional","affiliation":[{"name":"Renal Division, OPKO Health, Inc., Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3071-0700","authenticated-orcid":false,"given":"Keith C.","family":"Norris","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3330-0179","authenticated-orcid":false,"given":"Stuart M.","family":"Sprague","sequence":"additional","affiliation":[{"name":"NorthShore University Health System-University of Chicago, Pritzker School of Medicine, Evanston, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"1","key":"B1-20251120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease: mineral and bone disorder","volume":"7","year":"2017","journal-title":"Kidney Int Suppl."},{"issue":"6","key":"B2-20251120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000524289","article-title":"Extended-release calcifediol effectively raises serum total 25-hydroxyvitamin D even in overweight non-dialysis chronic kidney disease patients with secondary hyperparathyroidism","volume":"53","author":"Bishop","year":"2022","journal-title":"Am J Nephrol."},{"issue":"4","key":"B3-20251120","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1159\/000544086","article-title":"Adjunctive active vitamin D decreases kidney function during treatment of secondary hyperparathyroidism with extended-release calcifediol in non-dialysis chronic kidney disease in a randomized trial","volume":"56","author":"Ashfaq","year":"2025","journal-title":"Am J Nephrol."},{"key":"B4-20251120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000546615","article-title":"Extended-release calcifediol normalized 1,25-Dihydroxyvitamin D and prevented progression of secondary hyperparathyroidism in hemodialysis patients in a pilot randomized clinical trial","author":"Bishop","year":"2025","journal-title":"Am J Nephrol."},{"issue":"4","key":"B5-20251120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000499187","article-title":"Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease","volume":"49","author":"Strugnell","year":"2019","journal-title":"Am J Nephrol."},{"issue":"4","key":"B6-20251120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ndt\/gfae293","article-title":"The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis, and after kidney transplantation: a European consensus statement","volume":"40","author":"Jorgensen","year":"2025","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B7-20251120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"B8-20251120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000450766","article-title":"Use of extended-release calcifediol to treat secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"44","author":"Sprague","year":"2016","journal-title":"Am J Nephrol."},{"key":"B9-20251120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jsbmb.2014.11.022","article-title":"Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation","volume":"148","author":"Petkovich","year":"2015","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B10-20251120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000541138","article-title":"Sustained reduction of elevated intact parathyroid hormone concentrations with extended-release calcifediol slows chronic kidney disease progression in secondary hyperparathyroidism patients","author":"Bishop","year":"2024","journal-title":"Am J Nephrol."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:03:37Z","timestamp":1786478617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000982"}},"subtitle":["Time to Update Conventional Wisdom?"],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000982","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]}}}